Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channels in dental nerve fibers are diverse membrane-spanning proteins that selectively permit the flow of potassium ions (K⁺), thereby regulating nerve fiber excitability, signal conduction, and the repolarization of action potentials. These channels—encompassing voltage-gated (KV), calcium-activated (KCa), inwardly rectifying (Kir), and two-pore domain (K2P) subtypes—are fundamentally involved in setting the electrical properties of the nerves in the dental pulp, and play critical roles in mediating pain, sensitivity, and overall nerve function in oral tissues[1][5]. Their activity modifies resting membrane potential and action potential dynamics, impacting the perception of pain and the effectiveness of local anesthetic agents[3].
Drugs may block or enhance potassium conductance, thereby altering nerve excitability and pain transmission. Blockers delay repolarization, enhancing nerve activity, while openers increase potassium efflux, reducing excitability and pain signaling[1][5].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel protein in dental nerve fibers (null).